NovaPoint Capital’s Merck MRK Stock Holding History

NovaPoint Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$243K	Buy	+1,892	New	+$221K	0.05%	149
2025 Q1	–	Sell	-2,068	Closed	-$206K	–	142
2024 Q4	$206K	Sell	2,068 -251	-11%	-$25.9K	0.06%	126
2024 Q3	$263K	Sell	2,319 -13	-0.6%	-$1.54K	0.08%	116
2024 Q2	$289K	Buy	2,332 +9	+0.4%	+$1.16K	0.1%	113
2024 Q1	$306K	Sell	2,323 -57	-2%	-$7.03K	0.11%	110
2023 Q4	$259K	Buy	2,380 +40	+2%	+$4.15K	0.1%	112
2023 Q3	$241K	Buy	2,340 +143	+7%	+$15.4K	0.1%	118
2023 Q2	$254K	Buy	2,197 +100	+5%	+$11.4K	0.09%	115
2023 Q1	$223K	Buy	2,097 +3	+0.1%	+$324	0.09%	119
2022 Q4	$232K	Buy	+2,094	New	+$214K	0.1%	112
2022 Q3	–	Sell	-2,327	Closed	-$212K	–	126
2022 Q2	$212K	Buy	+2,327	New	+$206K	0.09%	119
2020 Q4	–	Sell	-2,620	Closed	-$207K	–	111
2020 Q3	$207K	Buy	+2,620	New	+$205K	0.13%	97

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

NovaPoint Capital's MRK Position: Q2 2026 in Review

NovaPoint Capital opened a new position in Merck (MRK) in Q2 2026: 1,892 shares worth $243K. The stake represents 0.05% of the portfolio and ranks #149 among its holdings. This is a return to the name: NovaPoint Capital previously reported a position in MRK as recently as Q4 2024.

NovaPoint Capital first reported a position in MRK in Q3 2020 and has held it in 12 quarters since. The position peaked at $306K in Q1 2024. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

NovaPoint Capital held 1,892 shares of Merck worth $243K as of Q2 2026.
Merck was a new NovaPoint Capital position in Q2 2026.
Merck made up 0.05% of NovaPoint Capital's portfolio in Q2 2026, its #149 holding.
NovaPoint Capital first reported a position in Merck in Q3 2020 and has held it in 12 quarters since.
NovaPoint Capital's Merck position peaked at $306K in Q1 2024.
3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on NovaPoint Capital's 13F filing for Q2 2026, filed 6 Aug 2026.